Michael Lee Blum - Net Worth and Insider Trading

Michael Lee Blum Net Worth

The estimated net worth of Michael Lee Blum is at least $703 dollars as of 2024-11-13. Michael Lee Blum is the Chief Commercial Officer of Homology Medicines Inc and owns about 752 shares of Homology Medicines Inc (FIXX) stock worth over $703. Details can be seen in Michael Lee Blum's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Lee Blum has not made any transactions after 2023-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael Lee Blum

To

Michael Lee Blum Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Lee Blum owns 1 companies in total, including Homology Medicines Inc (FIXX) .

Click here to see the complete history of Michael Lee Blum’s form 4 insider trades.

Insider Ownership Summary of Michael Lee Blum

Ticker Comapny Transaction Date Type of Owner
FIXX Homology Medicines Inc 2023-01-09 Chief Commercial Officer

Michael Lee Blum Latest Holdings Summary

Michael Lee Blum currently owns a total of 1 stock. Michael Lee Blum owns 752 shares of Homology Medicines Inc (FIXX) as of January 9, 2023, with a value of $703.

Latest Holdings of Michael Lee Blum

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FIXX Homology Medicines Inc 2023-01-09 752 0.93 703

Holding Weightings of Michael Lee Blum


Michael Lee Blum Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Lee Blum has made a total of 1 transactions in Homology Medicines Inc (FIXX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Homology Medicines Inc is the sale of 136 shares on January 9, 2023, which brought Michael Lee Blum around $3,411.

Insider Trading History of Michael Lee Blum

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Lee Blum Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Lee Blum Ownership Network

Ownership Network List of Michael Lee Blum

No Data

Ownership Network Relation of Michael Lee Blum

Insider Network Chart

Michael Lee Blum Owned Company Details

What does Homology Medicines Inc do?

Who are the key executives at Homology Medicines Inc?

Michael Lee Blum is the Chief Commercial Officer of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .

Homology Medicines Inc (FIXX) Insider Trades Summary

Over the past 18 months, Michael Lee Blum made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 1,952 shares made by Julie Jordan , a net sale of 13,037 shares made by Arthur Tzianabos , and a net sale of 7,280 shares made by Paul Alloway .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Homology Medicines Inc Insider Transactions

No Available Data

Michael Lee Blum Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Lee Blum. You might contact Michael Lee Blum via mailing address: C/o Homology Medicines, Inc., 45 Wiggins Avenue, Bedford Ma 01730.